Improved Disease on NaF-PET/CT in a 66-Year-Old Male with mCRPC who Had a PSA response to Docetaxel (image)

Society of Nuclear Medicine

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.